Middle temporal corpus callosum impairment as a predictor of eight-week treatment outcome of drug-naïve first-episode psychosis patients: A pilot longitudinal study

Schizophr Res. 2021 Jun:232:95-97. doi: 10.1016/j.schres.2021.05.005. Epub 2021 May 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Corpus Callosum
  • Humans
  • Longitudinal Studies
  • Magnetic Resonance Imaging
  • Pharmaceutical Preparations*
  • Psychotic Disorders* / drug therapy
  • Treatment Outcome

Substances

  • Pharmaceutical Preparations